Alpha Cognition Inc (ACOG.CA) Stock Price, Quote, News and Overview
TSX-V:ACOG - TSX Venture Exchange - CA02074J2048 - Common Stock - Currency: CAD
ACOG.CA Quote, Performance and Key Statistics
TSX-V:ACOG (10/6/2023, 7:00:00 PM)
0.39
-0.06 (-14.29%)
The current stock price of ACOG.CA is 0.39 CAD. In the past month the price increased by 11.43%. In the past year, price decreased by -37.1%.
ACOG.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 261.54M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 188.23M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 185.09M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 121.39M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 89.95M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 82.42M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 78.27M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 25.45 | 76.72M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 16.17 | 65.22M | ||
| MDCX.CA | MEDICUS PHARMA LTD | N/A | 61.74M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 52.45M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 51.96M |
Related stock screener links
About ACOG.CA
Company Profile
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-09-19. The firm is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer's dementia, and as an intranasal formulation for traumatic brain injury. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. The company is in preclinical development for the treatment of ALS.
Company Info
Alpha Cognition Inc
301 - 1228 Hamilton Street, Null
Vancouver BRITISH COLUMBIA V6B 2E6 CA
CEO: Michael McFadden
Employees: 0
Phone: 16045649244.0
Alpha Cognition Inc / ACOG.CA FAQ
What is the stock price of Alpha Cognition Inc today?
The current stock price of ACOG.CA is 0.39 CAD. The price decreased by -14.29% in the last trading session.
What is the ticker symbol for Alpha Cognition Inc stock?
The exchange symbol of Alpha Cognition Inc is ACOG and it is listed on the TSX Venture Exchange exchange.
On which exchange is ACOG.CA stock listed?
ACOG.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for Alpha Cognition Inc stock?
6 analysts have analysed ACOG.CA and the average price target is 3.06 CAD. This implies a price increase of 684.62% is expected in the next year compared to the current price of 0.39. Check the Alpha Cognition Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Alpha Cognition Inc worth?
Alpha Cognition Inc (ACOG.CA) has a market capitalization of 33.89M CAD. This makes ACOG.CA a Nano Cap stock.
How many employees does Alpha Cognition Inc have?
Alpha Cognition Inc (ACOG.CA) currently has 0 employees.
What are the support and resistance levels for Alpha Cognition Inc (ACOG.CA) stock?
Alpha Cognition Inc (ACOG.CA) has a support level at 0.34 and a resistance level at 0.43. Check the full technical report for a detailed analysis of ACOG.CA support and resistance levels.
Should I buy Alpha Cognition Inc (ACOG.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACOG.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACOG.CA, evaluating the profitability, health, valuation and growth aspects
- Alpha Cognition Inc (ACOG.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Alpha Cognition Inc (ACOG.CA) Sales and EPS estimates to see what analysts future expectations are.
- Alpha Cognition Inc (ACOG.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Alpha Cognition Inc (ACOG.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Alpha Cognition Inc (ACOG.CA) Stock Chart to make your own analysis
- Alpha Cognition Inc (ACOG.CA) Latest news and press-releases to stay up to date.
Does Alpha Cognition Inc (ACOG.CA) stock pay dividends?
ACOG.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Alpha Cognition Inc (ACOG.CA)?
Alpha Cognition Inc (ACOG.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
ACOG.CA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ACOG.CA. When comparing the yearly performance of all stocks, ACOG.CA turns out to be only a medium performer in the overall market: it outperformed 64.51% of all stocks.
ACOG.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ACOG.CA. ACOG.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
ACOG.CA Financial Highlights
Over the last trailing twelve months ACOG.CA reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 12.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -239.04% | ||
| ROE | -839.02% | ||
| Debt/Equity | 0.89 |
ACOG.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to ACOG.CA. The Buy consensus is the average rating of analysts ratings from 6 analysts.